Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TransMed7 is a medical technology company specializing in the development of advanced, minimally invasive medical devices for tissue sampling and surgical intervention. The company utilizes its proprietary Zero-5 and Concorde technology platforms to create vacuum-assisted biopsy systems that feature a unique forward-cutting, rotating mechanism. These devices are designed to provide clinicians with high-quality, contiguous tissue cores across various applications, including breast, lung, and prostate oncology. TransMed7's portfolio aims to improve diagnostic accuracy and patient outcomes by reducing procedure complexity and trauma. The company is headquartered in California and maintains a robust pipeline of FDA-cleared products currently in commercial use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TransMed7.